After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’

With the post-IPO quiet period having come to an end, CEO Benny Sørensen, M.D., Ph.D., was free to sit down with Fierce to map out Hemab’s future.